Janssen Biotech | Belgium | - | - | Private Company More Centre National De La Recherche Scientif | France | - | - | Private Company More Merck Sharp & Dohme Corp. 1891 | United States | 10,000-50,000 | http://
Our robust AI prediction models are specifically trained in the fields of cancer and infectious diseases, offering a clinically validated predictive capability that sets us apart in the biotech space. This precision allows for the rapid discovery of therapeutically relevant and delivery modality agnostic...
In addition to his academic role, he is the founder of four biotech companies and a venture partner at Third Rock Ventures. Pamela L. Schwartzberg is a senior investigator at the National Institute of Allergy and Infectious Diseases. She completed her MD and PhD degrees at Columbia University ...
Join us in Rome on May 05-06, 2025, for an enriching experience that promises to drive innovation and progress in the field. Why to Attend The Vaccines World 2025 represents a premier forum for the exchange of cutting-edge research and innovations in the field of vaccines and immunology. ...
Pharmaceutical and Biotech industry representatives Government and public health officials Graduate and postgraduate students Non-profit organizations Journalists and science communicators International attendees Sponsors and exhibitors Patients and patient advocates WHY TO ATTEND Virology meet 2024 provides an int...
Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion in milestone payments. Image Credit: Adobe Stock Images/Htet Wai Phyo AbbVie and Neomorph have announced a collaboration and option-to-license agreement to dev...
Related Societies: Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct –Action on Antibiotics, Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Mi...
Support This activity is supported by independent educational grants from AstraZeneca, Daiichi Sankyo, Inc., Ferring Pharmaceuticals, Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies). Disclosure information is available at ...
Key trends include advancements in mRNA technology, emerging infectious diseases, and evolving vaccine regulations. Sponsorship opportunities are abundant, with potential partners such as major pharmaceutical companies, biotech startups, and Clinical Research Organizations (CROs). ...